“FIVE FREEDOMS” – NEWS FEED: With BioNTech Deal, Pfizer Becomes Latest to Bet on mRNA Vaccines

Pfizer has become the latest drug maker to bet that synthetic messenger RNA molecules (mRNA) can be a new source for vaccines. This morning, the New York pharma company cut a deal with BioNTech, of Germany, to co-develop mRNA vaccines for flu prevention.

READ Ben Fidler’s article in Xconomy